rofecoxib has been researched along with Anemia, Sickle Cell in 1 studies
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rofecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor approved for the treatment of pain and arthritis in adults." | 3.72 | Pharmacokinetics of rofecoxib in children with sickle cell hemoglobinopathy. ( Aranda, JV; Edwards, DJ; Frattarelli, DA; Haritos, D; Prescilla, RP, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prescilla, RP | 1 |
| Frattarelli, DA | 1 |
| Haritos, D | 1 |
| Aranda, JV | 1 |
| Edwards, DJ | 1 |
1 other study available for rofecoxib and Anemia, Sickle Cell
| Article | Year |
|---|---|
Pharmacokinetics of rofecoxib in children with sickle cell hemoglobinopathy.
Topics: Administration, Oral; Adolescent; Analgesics, Non-Narcotic; Anemia, Sickle Cell; Anti-Inflammatory A | 2004 |